{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T03:10:10Z","timestamp":1752289810570,"version":"3.41.2"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Recent molecular characterization of T\u2011lymphoblastic leukemia\/lymphoma (T-ALL\/LBL) has deepened our understanding of the pathogenesis and created a strong foundation for novel therapeutic strategies. Consequently, both the fifth edition of the World Health Organization and the International Consensus Classification systems for T-ALL\/LBL have identified genomic subtypes, some as provisional entities. However, due to the challenges encountered in uncovering these alterations, molecular testing modalities and algorithms in clinical laboratory algorithms remain inconsistent or incomplete.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cases from Session 8 of the 2023 Workshop of the Society for Hematopathology and the European Association for Haematopathology highlighted various T-ALL\/LBL genetic subtypes and showcased phenotypic diversity even among individuals with identical genetic abnormalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The data underscored the presence of significant genetic heterogeneity in T-ALL\/LBL, highlighting the diagnostic value of specific genomic features for accurate classification, differentiation between immature and mature T-lymphoid neoplasms, and detection of underlying germline predisposition disorders. Further, the range of available standard molecular testing methodologies, including ancillary immunohistochemical studies, was discussed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A comprehensive standardized testing of genomic abnormalities will advance T-ALL\/LBL characterization in future classification systems, as underscored by the cases submitted to Session 8 of SH2023. The genetic heterogeneity underscores the need for personalized therapies that target driver genomic abnormalities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf035","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T02:46:42Z","timestamp":1752288402000},"page":"76-84","source":"Crossref","is-referenced-by-count":0,"title":["Genomics of T-lymphoblastic leukemia\/lymphoma: 2023 SH\/EAHP workshop proceedings"],"prefix":"10.1093","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-5249","authenticated-orcid":false,"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"first","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga K","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas Southwestern Medical Center , Dallas, TX ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E","family":"Bueso-Ramos","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025071122463723300_CIT0001","doi-asserted-by":"publisher","first-page":"a035246","DOI":"10.1101\/cshperspect.a035246","article-title":"The genetics and mechanisms of T-cell acute lymphoblastic leukemia","volume":"10","author":"Gianni","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025071122463723300_CIT0002","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med."},{"key":"2025071122463723300_CIT0003","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"2025071122463723300_CIT0004","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemia: integrating morphological, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood."},{"key":"2025071122463723300_CIT0005","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0006","first-page":"1116","article-title":"Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia","volume":"90","author":"De Keersmaecker","year":"2005","journal-title":"Haematologica."},{"key":"2025071122463723300_CIT0007","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature."},{"key":"2025071122463723300_CIT0008","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet."},{"key":"2025071122463723300_CIT0009","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/jcm10173792","article-title":"Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia","volume":"10","author":"Iacobucci","year":"2021","journal-title":"J Clin Med"},{"key":"2025071122463723300_CIT0010","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.beha.2020.101193","article-title":"Molecular markers in ALL: clinical implications","volume":"33","author":"Kimura","year":"2020","journal-title":"Best Pract Res Clin Haematol."},{"key":"2025071122463723300_CIT0011","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025071122463723300_CIT0012","doi-asserted-by":"publisher","first-page":"e2120787119","DOI":"10.1073\/pnas.2120787119","article-title":"Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases","volume":"119","author":"Dai","year":"2022","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025071122463723300_CIT0013","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood."},{"key":"2025071122463723300_CIT0014","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41375-024-02264-0","article-title":"Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols","volume":"38","author":"Neumann","year":"2024","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0015","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41408-022-00613-9","article-title":"Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins","volume":"12","author":"Steiml\u00e9","year":"2022","journal-title":"Blood Cancer J."},{"key":"2025071122463723300_CIT0016","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"2025071122463723300_CIT0017","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ccell.2015.05.003","article-title":"CXCR4 is required for leukemia-initiating cell activity in T cell acute lymphoblastic leukemia","volume":"27","author":"Passaro","year":"2015","journal-title":"Cancer Cell."},{"key":"2025071122463723300_CIT0018","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2232","article-title":"Launching the T-cell-lineage developmental programme","volume":"8","author":"Rothenberg","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"2025071122463723300_CIT0019","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood."},{"key":"2025071122463723300_CIT0020","first-page":"121","volume-title":"Early T Cell Differentiation: Lessons From T-Cell Acute Lymphoblastic Leukemia, in Progress in Molecular Biology and Translational Science","author":"Tremblay","year":"2010"},{"key":"2025071122463723300_CIT0021","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell."},{"key":"2025071122463723300_CIT0022","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"key":"2025071122463723300_CIT0023","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med."},{"key":"2025071122463723300_CIT0024","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell."},{"key":"2025071122463723300_CIT0025","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood."},{"key":"2025071122463723300_CIT0026","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol."},{"key":"2025071122463723300_CIT0027","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.leu.2403657","article-title":"A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias","volume":"19","author":"Speleman","year":"2005","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0028","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood."},{"key":"2025071122463723300_CIT0029","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3900","article-title":"Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia","volume":"49","author":"Seki","year":"2017","journal-title":"Nat Genet."},{"key":"2025071122463723300_CIT0030","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1182\/blood.2020010510","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood."},{"key":"2025071122463723300_CIT0031","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell Leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov."},{"key":"2025071122463723300_CIT0032","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature."},{"key":"2025071122463723300_CIT0033","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41375-020-0761-9","article-title":"T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T\/myeloid","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0034","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0035","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch."},{"key":"2025071122463723300_CIT0036","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood."},{"key":"2025071122463723300_CIT0037","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","article-title":"Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine","volume":"96","author":"Morita","year":"2021","journal-title":"Am J Hematol."},{"key":"2025071122463723300_CIT0038","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J Exp Med."},{"key":"2025071122463723300_CIT0039","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Sanchez-Martin","year":"2017","journal-title":"Blood."},{"key":"2025071122463723300_CIT0040","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1172\/JCI35090","article-title":"Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia","volume":"118","author":"Chiang","year":"2008","journal-title":"J Clin Invest."},{"key":"2025071122463723300_CIT0041","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science."},{"key":"2025071122463723300_CIT0042","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest."},{"key":"2025071122463723300_CIT0043","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature."},{"key":"2025071122463723300_CIT0044","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.leu.2404008","article-title":"Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias","volume":"20","author":"Clappier","year":"2006","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0045","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ph14050443","article-title":"Deregulation of the interleukin-7 signaling pathway in lymphoid malignancies","volume":"14","author":"Lodewijckx","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"key":"2025071122463723300_CIT0046","doi-asserted-by":"publisher","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","article-title":"Tazemetostat: EZH2 inhibitor","volume":"13","author":"Straining","year":"2022","journal-title":"J Adv Pract Oncol."},{"key":"2025071122463723300_CIT0047","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat Genet."},{"issue":"1-2","key":"2025071122463723300_CIT0048","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(91)90247-A","article-title":"Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders","volume":"198","author":"van Dongen","year":"1991","journal-title":"Clin Chim Acta"},{"key":"2025071122463723300_CIT0049","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00191340","article-title":"Gene rearrangements and chromosomal translocations in T cell lymphoma\u2014diagnostic applications and their limits","volume":"426","author":"Griesser","year":"1995","journal-title":"Virchows Arch."},{"key":"2025071122463723300_CIT0050","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0213-9626(09)70042-3","article-title":"Notch 1 signalling in human T-cell development and leukemia","volume":"28","author":"Gonz\u00e1lez-Garc\u00eda","year":"2009","journal-title":"Inmunolog\u00eda."},{"key":"2025071122463723300_CIT0051","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol."},{"key":"2025071122463723300_CIT0052","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1182\/blood-2017-03-771162","article-title":"Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations","volume":"129","author":"Hu","year":"2017","journal-title":"Blood."},{"key":"2025071122463723300_CIT0053","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41375-022-01743-6","article-title":"How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing","volume":"37","author":"M\u00fcller","year":"2023","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0054","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood."},{"key":"2025071122463723300_CIT0055","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/gcc.22971","article-title":"Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias","volume":"60","author":"Lestringant","year":"2021","journal-title":"Genes Chromosomes Cancer."},{"key":"2025071122463723300_CIT0056","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1182\/blood-2024-211561","article-title":"Genomic profiling of T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) for identification of driver aberrations using combined next generation sequencing and optical genome mapping in clinical diagnostic laboratory","volume":"144","author":"Sarami","year":"2024","journal-title":"Blood."},{"key":"2025071122463723300_CIT0057","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.semdp.2023.04.003","article-title":"Emerging molecular subtypes and therapies in acute lymphoblastic leukemia","volume":"40","author":"Davis","year":"2023","journal-title":"Semin Diagn Pathol."},{"key":"2025071122463723300_CIT0058","first-page":"1523","article-title":"Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia","volume":"9","author":"van Wering","year":"1995","journal-title":"Leukemia."},{"key":"2025071122463723300_CIT0059","first-page":"3570","article-title":"Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)","volume":"61","author":"Varon","year":"2001","journal-title":"Cancer Res."},{"key":"2025071122463723300_CIT0060","first-page":"ECR27","article-title":"T-cell lymphoblastic leukemia\/lymphoma in Nijmegen breakage syndrome","volume":"89","author":"Pasic","year":"2004","journal-title":"Haematologica."},{"key":"2025071122463723300_CIT0061","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/1\/76\/63730614\/aqaf035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/1\/76\/63730614\/aqaf035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T02:46:44Z","timestamp":1752288404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/1\/76\/8196900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,11]]},"published-print":{"date-parts":[[2025,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf035","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]}}}